PMV Pharma Stock (NASDAQ: PMVP) stock price, news, charts, stock research, profile.
Open | $1.790 |
Close | $1.820 |
Volume / Avg. | 457.060K / 548.969K |
Day Range | 1.730 - 1.820 |
52 Wk Range | 1.175 - 9.720 |
Market Cap | $93.627M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 41 |
Short Interest | 5.87% |
Days to Cover | 4.22 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of PMV Pharma (NASDAQ: PMVP) through any online brokerage.
Other companies in PMV Pharma’s space includes: Anixa Biosciences (NASDAQ:ANIX), Cellectar Biosciences (NASDAQ:CLRB), Connect Biopharma Hldgs (NASDAQ:CNTB), T2 Biosystems (NASDAQ:TTOO) and Armata Pharmaceuticals (AMEX:ARMP).
The latest price target for PMV Pharma (NASDAQ: PMVP) was reported by HC Wainwright & Co. on Thursday, May 30, 2024. The analyst firm set a price target for 5.00 expecting PMVP to rise to within 12 months (a possible 174.73% upside). 8 analyst firms have reported ratings in the last year.
The stock price for PMV Pharma (NASDAQ: PMVP) is $1.82 last updated May 31, 2024 at 4:03 PM EDT.
There are no upcoming dividends for PMV Pharma.
PMV Pharma’s Q2 earnings are confirmed for Wednesday, August 7, 2024.
There is no upcoming split for PMV Pharma.
PMV Pharma is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.